Skip to content

Long Follow up on Patients With Obstructive Sleep Apnea That Undergo Diagnosis and Surgical Treatment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02976207
Acronym
OSA
Enrollment
200
Registered
2016-11-29
Start date
2017-01-31
Completion date
Unknown
Last updated
2016-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OSA

Brief summary

Long follow up on patients with obstructive sleep apnea that undergo diagnosis and surgical treatment

Detailed description

Drug induced sleep endoscopy (DISE) is increasingly performed procedure, offering dynamic upper airway evaluation during artificial sleep before surgical treatment for patients with obstructed .)OSA(sleep apnea * Aim: To evaluate the value of DISE for tailoring the proper treatment for patients with snoring and OSA DISE is a safe procedure, easily practicable, valid and reliable. We consider it a fundamental clinical procedure that is essential before choosing the surgical treatment. Our results so far suggest that a multilevel collapse is significantly associated with higher apnea hypopnea index values. We think that the weight did not play a significant role in RDI (Respiratory Disturbance Index) reduction. Our results till now show tailored surgery based on DISE may leverage sleep surgeries outcome significantly presenting 70% success rate based * on our experience We therefore want to evaluate the patients in a long follow up period

Interventions

None listed

Sponsors

Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Fully diagnosed patients with OSA. * Patients who are candidates for a surgery as a treatment to their condition.

Exclusion criteria

* Pregnancy * Patients who are not OSA surgery candidates. * Patients with high surgical risk. * Patients with hematological or oncological background.

Design outcomes

Primary

MeasureTime frame
Measurement of daytime sleepiness- using Epworth sleepiness scale questionnaireup to 3 years after surgery
Sleep quality assessment questionnaireup to 3 years after surgery

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026